<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03441802</url>
  </required_header>
  <id_info>
    <org_study_id>olio1_FDG</org_study_id>
    <nct_id>NCT03441802</nct_id>
  </id_info>
  <brief_title>Gut Microbiota as a Therapeutic Target for CVD</brief_title>
  <acronym>oliomicroFDG</acronym>
  <official_title>Gut Microbiota as a Novel Therapeutic Target for Prevention of Cardiovascular Diseases in Obese and Non-obese Adult Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Don Carlo Gnocchi Onlus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Don Carlo Gnocchi Onlus</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: The Mediterranean Diet (MD) is considered an healthy diet useful in the
      prevention of cardiovascular disease (CVD). High quality extra virgin olive oil (HQ-EVOO,
      [1]), an essential component of this diet, exerts a protective effect against CVD. Moreover,
      the gut microbiota (GM) has recently been recognized as a key factor in driving metabolic
      activities and involved in the stimulation of host immunity [2]. In particular, Lactic Acid
      Bacteria (LAB) and their probio-active cellular substances produce beneficial effects in the
      gastrointestinal tract, thus representing important assets in pathological conditions such as
      obesity and CVD [3,4].

      Objective: The purpose of this study is to demonstrate that 3 months of treatment (MD with
      40g/die HQ-EVOO) in 36 subjects (cases: overweight/obese vs controls: normal weight) may
      change their GM and inflammatory panel.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 8, 2014</start_date>
  <completion_date type="Actual">February 6, 2017</completion_date>
  <primary_completion_date type="Actual">June 6, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>anti-inflammatory cytokines</measure>
    <time_frame>Time 0 (T0)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in anti-inflammatory cytokines</measure>
    <time_frame>after 3 months from T0 (T1)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High quality extra virgin olive oil</intervention_name>
    <description>Cases and controls were given 40 g/die high quality extra virgin olive oil</description>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  normal weight subjects (M and F) with Body Mass Index (BMI) between 18.5 and 24.9
             Kg/m2 following MD;

          -  overweight/obese subjects with a BMI ≥ 25 Kg/m2, not necessarily following MD.

        Exclusion Criteria:

          -  eating disorders;

          -  recent or ongoing antibiotic therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>1) Oliveras-López M-J, Berná G, Jurado-Ruiz E, López-García de la Serrana H, Martín F. Consumption of extra-virgin olive oil rich in phenolic compounds has beneficial antioxidant effects in healthy human adults. J Funct Foods 2014;10:475-84</citation>
  </reference>
  <reference>
    <citation>2) Hervert-Hernández D, Goñi I. Dietary Polyphenols and Human Gut Microbiota: a Review. Food Reviews International. 2011;27:154-69.</citation>
  </reference>
  <reference>
    <citation>Woting A, Blaut M. The Intestinal Microbiota in Metabolic Disease. Nutrients. 2016 Apr 6;8(4):202. doi: 10.3390/nu8040202. Review.</citation>
    <PMID>27058556</PMID>
  </reference>
  <reference>
    <citation>Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016 Apr 20;8(1):42. doi: 10.1186/s13073-016-0303-2. Review.</citation>
    <PMID>27098727</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2018</study_first_submitted>
  <study_first_submitted_qc>February 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2018</study_first_posted>
  <last_update_submitted>February 15, 2018</last_update_submitted>
  <last_update_submitted_qc>February 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

